Q BioMed Inc.

QBIO · OTC
Analyze with AI
11/30/2022
11/30/2021
11/30/2020
11/30/2019
Operating Activities
Net Income-$2,052-$8,241-$13,492-$10,280
Dep. & Amort.$50$50$50$50
Deferred Tax$0$345$375$799
Stock-Based Comp.$904$2,339$6,574$2,496
Change in WC$1,752$797$313$1,697
Other Non-Cash$1,288$408-$53$1,132
Operating Cash Flow$1,941-$4,302-$6,233-$4,105
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$3,143$0$0$0
Investing Cash Flow-$3,143$0$0$0
Financing Activities
Debt Repay.$653$3,459$1,965$970
Stock Issued$100$1,010$323$623
Stock Repurch.$0$0$0$0
Dividends Paid$0-$501-$375$0
Other Fin. Act.$155$501$375$0
Financing Cash Flow$908$4,469$6,238$1,593
Forex Effect$0$0$0$0
Net Chg. in Cash-$294$167$5-$2,512
Supplemental Information
Beg. Cash$344$177$173$2,684
End Cash$50$344$177$173
Free Cash Flow$1,941-$4,302-$6,233-$4,105
Q BioMed Inc. (QBIO) Financial Statements & Key Stats | AlphaPilot